This federal contract award, valued at $1,713.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, a Delivery Order (SPE2DB25FT6V1) under a larger Indefinite Delivery Contract (SPE2DB20D3505), is for the supply of Ondansetron HCL 4 mg tablets. The contract has a firm fixed-price pricing type and a completion date of December 24, 2024. Amerisourcebergen, a for-profit organization, is the prime contractor for this award, which does not have a set-aside designation. The contract is part of DLA's broader efforts to procure essential pharmaceutical products and medical supplies to support military healthcare programs and federal beneficiaries.
Generated 3/24/25, 9:53 AM